Loading...

LEIGH SYNDROME & MITOCHONDRIAL ENCEPHALOPATHY GENE PANEL BY NGS, EDTA BLOOD

image not found

NABL Cap Accredited 
The Leigh Syndrome & Mitochondrial Encephalopathy Gene Panel by NGS evaluates critical nuclear and mitochondrial genes involved in energy production and neurological function. Using an EDTA blood sample, this test identifies inherited variants responsible for progressive neurological decline, metabolic crises, and mitochondrial dysfunction. Metropolis Healthcare uses advanced next-generation sequencing to ensure precise and comprehensive detection of disease-causing mutations. The results support early diagnosis, targeted management, and informed family counseling


 

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 21,000.00

Sample Type: EDTA BLOOD

Fasting Not Required


Notes:G0216

Frequently Asked Questions (FAQ's):

 What does the Leigh Syndrome & Mitochondrial Encephalopathy Gene Panel include at Metropolis Healthcare?

It analyzes both mitochondrial and nuclear genes associated with energy metabolism using high-accuracy NGS technology.

How does Metropolis Healthcare perform this test?
Metropolis Healthcare extracts DNA from an EDTA blood sample and sequences targeted regions to detect pathogenic variants linked to mitochondrial encephalopathies.

Who should consider taking this test at Metropolis Healthcare?
Individuals with developmental regression, seizures, metabolic acidosis, or MRI features suggestive of mitochondrial disease may benefit from this panel.

What sample is required for this test at Metropolis Healthcare?
A standard EDTA blood sample is used for high-quality DNA extraction and next-generation sequencing.

How long does Metropolis Healthcare take to provide results?
Results are shared within a typical genetic testing timeline after detailed sequencing and expert interpretation.

Why choose Metropolis Healthcare for mitochondrial disorder testing?
Metropolis Healthcare offers comprehensive gene coverage, precise NGS-based mutation detection, and clinically actionable insights.

Does Metropolis Healthcare provide post-test guidance?
Yes, the report includes expert genetic interpretation to support clinical management and family risk assessment.

Is this test suitable for children at Metropolis Healthcare?
Yes, the panel is appropriate for infants, children, and adults with suspected mitochondrial encephalopathies

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab